Financial Daily from THE HINDU group of publications
Thursday, Aug 18, 2005
News
Features
Stocks
Port Info
Archives
Google

Group Sites

 Corporate - Announcements


Glenmark launches osteoporosis drug

Our Bureau

Mumbai , Aug. 17

INDIA has more than 12 million cases of osteporosis and Glenmark Pharmaceuticals Ltd expects to cater to this market with its recently launched medicine, Stronat.

The drug, Strontium Ranelate, sold under the brand name Stronat will be marketed through its two divisions, Glenmark and Integrace. Stronat is a once-a-day therapy that will be sold on prescriptions, a company note said.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
L&T, Hong Kong co bag Hyderabad airport orders

ClinInvent to start trials for respiratory drug
TVS Motor to hand over acquired co to new management
Rajasthan Spinning to raise $25 m thru debt, equity
GAIL in talks to secure LNG for Dabhol
Glenmark launches osteoporosis drug
Mirza Tanners is now Mirza International
FLAG complains to TRAI about VSNL blocking access
Single window for M&A
IOC awaits Govt nod for IBP merger
Hyundai to invest $600 m in new plant, product development — Launches premium sedan Sonata `Embera'
Bombay Rayon plans IPO
Nicco plans telecom cable unit in Assam
GHCL looking to buy home textile cos in US, Europe
Chittivalasa Jute Mills lifts lockout
ONGC-Mittal combine bids for PetroKazakhstan
Sujana ties up with Bajaj Electricals
DCM Shriram approves stock split, bonus issue
Havell's India gets Dutch certification

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line